Abstract: Kits and methods for diagnosing risk of developing lung cancers and uses thereof are described. In a first aspect, described herein are lung cancer risk test kits that include reagents for measurement of multiple low VAF (defined as VAF<1%) mutants in a set of lung cancer driver genes; and, instructions therefor.
Type:
Application
Filed:
September 8, 2020
Publication date:
October 27, 2022
Applicant:
The University of Toledo
Inventors:
James C. Willey, Daniel J. Craig, Thomas M. Blomquist, Erin L. Crawford, Ji-Youn Yeo
Abstract: Methods for controlling for non-systematic error in an amplification-based next generation sequencing (NGS) library preparation are described, which method includes using an internal amplification control (IAC) sharing identical priming sites to a native nucleic acid target template of interest in a NGS library preparation.
Type:
Application
Filed:
April 25, 2022
Publication date:
September 8, 2022
Applicant:
The University of Toledo
Inventors:
James C. Willey, Thomas Blomquist, Erin Crawford
Abstract: Bioactive glass compositions, composites of the bioactive glass compositions with polymers, and 3D printable filaments made from the same, along with methods of making and using the same, are described. In some embodiments, the compositions, composites, and filaments have antibacterial activity.
Abstract: A minimally invasive blood clot capturing invention made of nitinol. The nitinol is shaped into a plurality of fingers to form a frame for a basket and funnel to capture and remove blood clots. The basket and funnel being delivered to the blood clot by a catheter. The basket and funnel are capable of being collapsed within a catheter, capable of being deployed into a blood vessel, and capable of being retracted into the catheter for removal from the blood vessel.
Type:
Grant
Filed:
March 13, 2018
Date of Patent:
August 23, 2022
Assignee:
The University of Toledo
Inventors:
Christopher J. Cooper, Mohammad H. Elahinia, Rajesh Gupta, Hamdy Ibrahim
Abstract: Compounds, compositions, and methods useful for inducing cancer cell death via methuosis, autophagy, or a combination thereof, are described. The compounds have a 4-pyridyl group linked by a heterocyclic group to an aryl, heteroaryl, aralkyl, or heteroaryl alkyl.
Type:
Grant
Filed:
September 26, 2018
Date of Patent:
August 9, 2022
Assignee:
The University of Toledo
Inventors:
Amit K. Tiwari, Chandrabose Karthikeyan, Haneen Amawi, Paul W. Erhardt, Piyush Trivedi
Abstract: An optoelectronic device comprising two photovoltaic absorber materials of CdSeTe and perovskite and their functional component layers that are monolithically integrated into a bifacial tandem solar cell structure.
Type:
Application
Filed:
November 18, 2021
Publication date:
June 23, 2022
Applicant:
The University of Toledo
Inventors:
Zhaoning Song, Kamala Khanal Subedi, Randy Ellingson, Yanfa Yan
Abstract: Described herein are compositions, formulations, and methods useful for sensitizing cancer cells to chemotherapeutic agents, for inhibiting expression or translation of oncogenic proteins, for inhibiting eIF4A, for inhibiting c-MYC, for reducing sternness of breast cancer cells, for treating breast cancer, for overcoming drug resistance of drug-resistant cancer cells, and for reducing tumor cell viability, involving one or more inhibitors of eIF4A, LASP1, CXCR4, CXCL8, CXCL12, ROCK1, BIRC5, MDM2, CCND1, and c-MYC.
Type:
Application
Filed:
February 17, 2020
Publication date:
May 19, 2022
Applicant:
The University of Toledo
Inventors:
Dayanidhi Raman, Cory M. Howard, John Nemunaitis, Francis Charles Brunicardi, Shi-He Liu, Amit K. Tiwari
Abstract: Compositions and methods for the treatment of obesity, hyperlipidemia, fatty liver disease, cardiovascular disease and type II diabetes are described. Also described are compositions and methods for decreasing one or more of body weight, total fat, percent fat mass, visceral fat, epididymal fat, hepatic fat content, fasting blood glucose, decreasing white adipose fat (WAT) adipocyte size, or increasing percent lean mass. The compositions and methods involve PEGylated bilirubin.
Abstract: Methods for controlling for non-systematic error in an amplification-based next generation sequencing (NGS) library preparation are described, which method includes using an internal amplification control (IAC) sharing identical priming sites to a native nucleic acid target template of interest in a NGS library preparation.
Type:
Grant
Filed:
March 1, 2018
Date of Patent:
April 26, 2022
Assignee:
The University of Toledo
Inventors:
James C. Willey, Thomas Blomquist, Erin Crawford
Abstract: Described herein is a diffusion-based ex-situ group V element doping method in the CdCl2 heat-treated polycrystalline CdTe film. The ex-situ doping using group V halides, such as PCl3, AsCl3, SbCl3, or BiCl3, demonstrated a promising PCE of ˜18% and long-term light soaking stability in CdSe/CdTe and CdS/CdTe devices with decent carrier concentration>1015 cm?3. This ex-situ solution or vapor process can provide a low-cost alternative pathway for effective doping of As, as well as P, Sb, and Bi, in CdTe solar cells with limited deviation from the current CdTe manufacturing process.
Type:
Grant
Filed:
March 3, 2021
Date of Patent:
February 22, 2022
Assignees:
THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA, The University of Toledo
Abstract: Hole transport layers, electron transport layers, layer stacks, and optoelectronic devices involving perovskite materials and materials used as precursors, and methods of making the same, are described.
Type:
Grant
Filed:
January 26, 2018
Date of Patent:
February 15, 2022
Assignee:
The University of Toledo
Inventors:
Randall J. Ellingson, Khagendra P. Bhandari, Michael Heben, Suneth Watthage, Zhaoning Song
Abstract: Described herein are immunoresponsive cells which are useful for their preventive and therapeutic potential against autoimmune diseases and rejections of solid organ transplants.
Abstract: Compositions and methods for preventing, treating, or delaying the onset of rheumatoid arthritis involving 14-3-3?, are described. Provided is a method for preventing, treating, or delaying the onset of rheumatoid arthritis, the method comprising administering an effective amount of 14-3-3?, or a variant thereof, to a subject at risk for developing rheumatoid arthritis, and preventing, treating, or delaying the onset of rheumatoid arthritis in the subject.
Abstract: Described herein are materials and methods useful for the treatment of neurodegenerative disorders and bone disorders, as well as healing wounds, in a subject. Materials described herein include polysaccharide digestive products resulting from the enzymatic hydrolysis of low acyl gellan gum. Also described herein are pharmaceutical compositions comprising one or more of such materials, and methods for their preparation and use.
Abstract: Methods for forming electrical contacts with CdTe layers, methods for forming photovoltaic devices, methods for passivating a CdTe surface, and photovoltaic devices are described.
Type:
Grant
Filed:
April 29, 2020
Date of Patent:
November 30, 2021
Assignee:
The University of Toledo
Inventors:
Michael J. Heben, Adam B. Phillips, Fadhil K. Alfadhili, Randall J. Ellingson, Ebin Bastola, Dipendra Pokhrel, Kamala Khanal Subedi